Table of Contents Section 1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Definition Section 2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Manufacturer Share and Market Overview 2.1 Global Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments 2.2 Global Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Revenue 2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview Section 3 Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction 3.1 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction 3.1.1 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments, Price, Revenue and Gross profit 2014-2019 3.1.2 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Distribution by Region 3.1.3 Astellas Pharmaceuticals Interview Record 3.1.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Profile 3.1.5 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification 3.2 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction 3.2.1 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments, Price, Revenue and Gross profit 2014-2019 3.2.2 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Distribution by Region 3.2.3 Interview Record 3.2.4 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Overview 3.2.5 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification 3.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction 3.3.1 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments, Price, Revenue and Gross profit 2014-2019 3.3.2 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Distribution by Region 3.3.3 Interview Record 3.3.4 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Overview 3.3.5 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification 3.4 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction 3.5 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction 3.6 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction … Section 4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Region Level) 4.1 North America Country 4.1.1 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.1.2 Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.2 South America Country 4.2.1 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.3 Asia Country 4.3.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.3.2 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.3.3 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.3.4 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.4 Europe Country 4.4.1 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.4.2 UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.4.3 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.4.4 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.4.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.5 Other Country and Region 4.5.1 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.5.2 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.5.3 GCC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Price Analysis 2014-2019 4.6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Region Level) Analysis 2014-2019 4.7 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Region Level) Analysis Section 5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Product Type Level) 5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Product Type Level) Market Size 2014-2019 5.2 Different Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type Price 2014-2019 5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Product Type Level) Analysis Section 6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Industry Level) 6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Industry Level) Market Size 2014-2019 6.2 Different Industry Price 2014-2019 6.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Industry Level) Analysis Section 7 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Channel Level) 7.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Channel Level) Sales Volume and Share 2014-2019 7.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Channel Level) Analysis Section 8 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast 2019-2024 8.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Region Level) 8.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Product Type Level) 8.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Industry Level) 8.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Channel Level) Section 9 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Product Type 9.1 Preface Product Introduction 9.2 Eluxadoline Product Introduction 9.3 Alosetron Product Introduction 9.4 Rifaximin Product Introduction 9.5 Loperamide/Diphenoxylate + Atropine/Dicyclomine and Hyoscyamine Product Introduction Section 10 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Industry 10.1 Hospitals Clients 10.2 Clinics Clients 10.3 Others Clients Section 11 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Cost of Production Analysis 11.1 Raw Material Cost Analysis 11.2 Technology Cost Analysis 11.3 Labor Cost Analysis 11.4 Cost Overview Section 12 Conclusion Chart and Figure Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Picture from Astellas Pharmaceuticals Chart 2014-2019 Global Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments (Units) Chart 2014-2019 Global Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments Share Chart 2014-2019 Global Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Revenue (Million USD) Chart 2014-2019 Global Manufacturer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Revenue Share Chart Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments, Price, Revenue and Gross profit 2014-2019 Chart Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Distribution Chart Astellas Pharmaceuticals Interview Record (Partly) Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Picture Chart Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Profile Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification Chart Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments, Price, Revenue and Gross profit 2014-2019 Chart Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Distribution Chart Actavis Interview Record (Partly) Figure Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Picture Chart Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Overview Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification Chart Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Shipments, Price, Revenue and Gross profit 2014-2019 Chart Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Distribution Chart Pfizer Interview Record (Partly) Figure Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Picture Chart Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Overview Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification 3.4 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Introduction … Chart United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart GCC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019 Chart GCC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price ($/Unit) 2014-2019 Chart Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Region Level) Sales Volume 2014-2019 Chart Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Region Level) Market size 2014-2019 Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Product Type Level) Volume (Units) 2014-2019 Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Product Type Level) Market Size (Million $) 2014-2019 Chart Different Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type Price ($/Unit) 2014-2019 Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Industry Level) Market Size (Volume) 2014-2019 Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Industry Level) Market Size (Share) 2014-2019 Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Industry Level) Market Size (Value) 2014-2019 Chart Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Channel Level) Sales Volume (Units) 2014-2019 Chart Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation (Channel Level) Share 2014-2019 Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Region Level) 2019-2024 Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Product Type Level) 2019-2024 Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Industry Level) 2019-2024 Chart Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segmentation Market Forecast (Channel Level) 2019-2024 Chart Preface Product Figure Chart Preface Product Advantage and Disadvantage Comparison Chart Eluxadoline Product Figure Chart Eluxadoline Product Advantage and Disadvantage Comparison Chart Alosetron Product Figure Chart Alosetron Product Advantage and Disadvantage Comparison Chart Rifaximin Product Figure Chart Rifaximin Product Advantage and Disadvantage Comparison Chart Loperamide/Diphenoxylate + Atropine/Dicyclomine and Hyoscyamine Product Figure Chart Loperamide/Diphenoxylate + Atropine/Dicyclomine and Hyoscyamine Product Advantage and Disadvantage Comparison Chart Hospitals Clients Chart Clinics Clients Chart Others Clients